Hepatitis C Genotypes: The Key to Pathogenicity?

Editorials1 February 1995Hepatitis C Genotypes: The Key to Pathogenicity?Paul Martin, MDPaul Martin, MDUniversity of California at Los Angeles, Los Angeles, CA 90024Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-122-3-199502010-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Although investigation of the hepatitis C virus (HCV) has proceeded rapidly since the virus was discovered, numerous important issues about HCV, including the risk for disease progression in patients with chronic HCV infection and the role of interferon therapy, require clarification. This discussion focuses on predictors of both disease progression and response to interferon therapy; in particular, it considers the ways in which new research on HCV genotypes may shed light on these important and unresolved questions.As it would for any chronic disease, an understanding of the natural history of HCV provides a basis for rational decisions about management ...References1. Alter HJ. Chronic consequences of non-A, non-B hepatitis. In: Seeff LB, Lewis JH, eds. Current Perspectives in Hepatology: Festschrift for Hyman J. Zimmerman, M.D. New York: Plenum Medical; 1989:83-97. Google Scholar2. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med. 1993; 119:110-5. Google Scholar3. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter JH, Iber FL, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992; 327:1906-11. Google Scholar4. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, and Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case–control study. Ann Intern Med. 1992; 116:97-102. Google Scholar5. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990; 12:671-5. Google Scholar6. Caldwell SH, Li X, Rourk RM, Millar A, Sosnowski KM, Sue M, et al. Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol. 1993; 88:1016-21. Google Scholar7. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989; 97:1559-61. Google Scholar8. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991; 14:381-8. Google Scholar9. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992; 73(Pt 3):673-9. Google Scholar10. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994; 32:884-92. Google Scholar11. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993; 74(Pt 6):1093-102. Google Scholar12. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes (Letter). Hepatology. 1994; 19:1321-4. Google Scholar13. Takada N, Takase A, Takada A, Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol. 1993; 17:277-83. Google Scholar14. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994; 19:13-8. Google Scholar15. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-2a therapy in patients with chronic hepatitis C. Dig Dis Sci. 1994; 39:1273-80. Google Scholar16. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci. 1994; 39:977-82. Google Scholar17. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 1994; 122:161-8. Google Scholar18. Lau JY, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL, et al. Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet. 1993; 342:1208-9. Google Scholar19. Orito E, Mizokami M, Mizoguchi N, et al. Hepatitis C virus serotype II responds more favorably to interferon-therapy. J Hepatol. 1994; 21:130-2. Google Scholar20. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infection with HCV types 1, 2, and 3. J Clin Microbiol. 1993; 31:1493-503. Google Scholar Author, Article, and Disclosure InformationAffiliations: University of California at Los Angeles, Los Angeles, CA 90024Corresponding Author: Paul Martin, MD, Division of Digestive Diseases, Center for the Health Sciences, University of California at Los Angeles, Los Angeles, CA 90024.Acknowledgments: The author thanks Judy Grimes for excellent secretarial help and Johnson Y.N. Lau, MD, for helpful suggestions. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHepatitis C Virus Type 1b (II) Infection in France and Italy Jean-Baptiste Nousbaum , Stanislas Pol , Bertrand Nalpas , Paul Landais , Pierre Berthelot , Christian Brechot , and Metrics Cited ByAn overview about hepatitis C: A devastating virusHepatitis CSerotype Analysis of Hepatitis C Virus in Patients with Liver Cirrhosis Positive and Negative for HCV RNA Using Enzyme ImmunoassayClinical Usefulness of a New Hepatitis C Virus RNA Extraction Method Using Specific Capture Probe and Magnetic Particle in Hemodialysis PatientsProgression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusHepatitis C Virus Infection and B-Cell Non-Hodgkin's Lymphomas: More Than a Simple AssociationDiagnostic Workup of Hepatitis C and the Patient on Maintenance DialysisHepatitis C virus infection and renal transplantationSerotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patientsRelationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypesRisk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control studyHepatitis C: An Emerging DilemmaMolecular epidemiology of hepatitis C in AustraliaIs Long-Term Chronic Immunosuppression Therapy Detrimental in Hepatitis C Virus–Positive Renal Transplant Patients?HEPATITIS C–ASSOCIATED AUTOIMMUNE DISORDERSIMPACT OF HEPATITIS C VIRUS DURATION AND HEPATITIS C VIRUS GENOTYPES ON RENAL TRANSPLANT PATIENTSHepatitis C virus infection and autoimmunityTyping of Hepatitis C Virus Antibody with Specific Peptides in Seropositive Blood Donors and Comparison with Genotyping of Viral RNAAssessment of commercial enzyme immunoassay for hepatitis C virus serotyping.Correlation between Serological and Genetic Methods for Typing Hepatitis C VirusRECENT PULMONARY OBSERVATIONS IN α1-ANTITRYPSIN DEFICIENCY, PRIMARY BILIARY CIRRHOSIS, CHRONIC HEPATITIS C, AND OTHER HEPATIC PROBLEMSA PROSPECTIVE STUDY OF HEPATITIS C VIRUS INFECTION IN RENAL ALLOGRAFT RECIPIENTS1, 2Hepatitis C and the Renal Transplant PatientInfection outcome in hemodialysis patients and kidney recipientsEvaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologiesChronic viral hepatitis and the management of chronic renal failure 1 February 1995Volume 122, Issue 3Page: 227-228KeywordsBiopsyChronic hepatitisCirrhosisHepatocellular carcinomaInfectious diseasesInterferonsLiver diseasesProteinsRNAViral load Issue Published: 1 February 1995 CopyrightCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...